Pilot study comparing technologies to test for substandard drugs in field settings

African Journal of Pharmacy and Pharmacology

Volumn 3, Issue 4, 2009, Pages 165-170

  Bate, Roger ^a,b   Tren, Richard ^b,c   Hess, Kimberly ^b   Mooney, Lorraine ^d   Porter, Karen ^a  

^a AMERICAN ENTERPRISE INSTITUTE   (United States)

^b Africa Fighting Malaria   (United States)

^c Africa Fighting Malaria   (South Africa)

^d Africa Fighting Malaria   (United Kingdom)

Author keywords

Counterfeit and substandard drug production; Raman and near infrared spectrometry; Regulation of drug quality; Thin layer chromatography

Indexed keywords

AMODIAQUINE; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ANTIMYCOBACTERIAL AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CHLOROQUINE; CIPROFLOXACIN; DIHYDROARTEMISININ; ERYTHROMYCIN; FANSIDAR; ISONIAZID; MEFLOQUINE; RIFAMPICIN;

ARTICLE; CONCENTRATION (PARAMETERS); COST; DISINTEGRATION TEST; DRUG MANUFACTURE; DRUG QUALITY; DRUG SCREENING; INTERMETHOD COMPARISON; NEAR INFRARED SPECTROSCOPY; PILOT STUDY; RAMAN SPECTROMETRY; SENSITIVITY AND SPECIFICITY; THIN LAYER CHROMATOGRAPHY;

EID: 77953657633     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ahura Scientific, Inc. (2007). Technical Note 6.0. TruScan Compliance. Available: http://www.ahurascientific.com/download/pdf/TSTN06- TruScan%20Compliance-080707.pdf.
2. Amin AA, Snow RW, Kokwaro GO (2005). The quality of sulphadoxine- pyrimethamine and amodiaquine products in the Kenyan retail sector. J. Clin. Pharm. Therap. 30: 559-565.
3. Australian Government (2008). Australian Customs Service. Import Controls on Laser Pointers. Available: http://www.customs.gov.au/webdata/resources/ files/LaserPointers.pdf.
4. Bate R, Coticelli P, Tren R, Attaran A (2008). Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa - A Six Country Study. PLoS ONE. 3(5):e2132.
5. Deisingh AK (2005). Pharmaceutical Counterfeiting. Analyst. 130: 271-279.
6. Frosch T, Schmitt M, Popp J (2007). Raman spectroscopic investigation of the antimalarial agent mefloquine. Anal Bioanal Chem. 387: 1749-1757.
7. Global Pharma Health Fund. The GPHF-Minilab® - Protection Against Counterfeited and Substandard Pharmaceuticals. Available: http://www.gphf.org/ web/en/minilab/index.htm.
8. Lon CT, Tsuyuoka R, Phanouvong S, Nivanna N, Socheat D, Sokhan C, Blum N, Christophel EM, Smine A (2006). Counterfeit and substandard antimalarial drugs in Cambodia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100(11):1019-1024.
9. McCreery RL, Horn AJ, Spencer J, Jefferson E (1998). Noninvasive Identification of Materials inside USP Vials with Raman Spectroscopy and a Raman Spectral Library. J. Pharm. Sci. 87(1):1-8.
10. Minzi OMS, Moshi MJ, Hipolite D, Massele AY, Tomson G, Ericsson O, Gustafsson LL (2003). Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania. J. Clin. Pharm. Therap. 28:117-122.
11. Polychromix. Phazir RX. Satisfying GMP with Handheld Near-Infrared Analyzers in the Pharmaceutical Industry. Available: http://www.polychromix.com/ PDF/pharma.pdf.
12. Ricci C, Eliasson C, Macleod NA, Newton PN, Matousek P, Kazarian SG (2007). Characterization of genuine and fake artesunate anti-malarial tablets using Fourier transform infrared imaging and spatially offset Raman spectroscopy through blister packs. Anal Bioanal Chem. 389: 1525-1532.
13. Ricci C, Nyadong L, Yang F, Fernandez FM, Brown CD, Newton PN, Kazarian SG (2008). Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate antimalarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometry. Anal Chim Acta. 623(2):178-186.
14. Sherma J (2007). Analysis of Counterfeit Drugs by Thin Layer Chromatography. ACTA Chromatographica. No. 19.
15. US Food and Drug Administration (1995). Guidance for Industry: Immediate Release Solid Oral Dosage Forms: Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation: Center for Drug Evaluation and Research (CDER). Available: http://www.fda.gov/cder/guidance/supac.htm.
16. Witkowski M (2005). The Use of Raman Spectroscopy in the Detection of Counterfeit and Adulterated Pharmaceutical Products. American Pharmaceutical Review. Available: http://www.americanpharmaceuticalreview.com/ViewArticle.aspx? SID=kjidu0vbitwpnhrjatbjthux&ContentID=210.
17. World Health Organization (2003). Fact sheet. Substandard and Counterfeit Medicines. Available: http://www.who.int/mediacentre/factsheets/2003/fs275/en/.
18. World Health Organization (2008). International Medical Products Anti-Counterfeiting Taskforce brochure. Counterfeit Drugs Kill! Available: http://www.who.int/impact/FinalBrochureWHA2008a.pdf.